Epidemiological profile and risk factors of HIV and HBV/HCV co‐infection in Fujian Province, southeastern China
Authors:
- 2 September 2016
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 89 (3) , 443-449
Abstract
This study aimed to investigate the epidemiological features of HIV‐infected subjects co‐infected with HBV/HCV in Fujian Province, southeastern China, and identify the risk factors. Blood samples were collected from 2,028 HIV antibody‐positive subjects in Fujian Province. Serum HBsAg and anti‐HCV antibody were detected, and CD4+ T cell count was measured. Of the 2,028 subjects, the prevalence of HIV‐HBV, HIV‐HCV, and HIV‐HBV‐HCV co‐infections was 16.22%, 3.7%, and 0.79%, respectively. Man (OR = 1.912, 95% CI: 1.371–2.667), key population (OR = 0.756, 95% CI: 0.57–0.976) and detainee (OR = 0.486, 95% CI: 0.259–0.909) were risk factors of HIV‐HBV co‐infection, and man (OR = 2.227, 95% CI: 1.096–4.525), minority (OR = 5.04, 95% CI: 1.696–14.98), junior high school or lower education (OR = 2.32, 95% CI: 1.071–5.025), intravenous drug use (OR = 38.46, 95% CI: 11.46–129.11) and detainee (OR = 5.687, 95% CI: 2.44–13.25) were risk factors of HIV‐HCV co‐infection. In addition, a lower mean CD4+ T cell count was measured in HIV/HBV and HIV/HCV co‐infected subjects than in HIV‐infected subjects among the untreated individuals, while in the treated populations, a higher mean CD4+ T cell count was detected in HIV/HBV and HIV/HCV co‐infected subjects than in HIV‐infected subjects. HIV co‐infection with HBV or HCV, notably HIV‐HBV co‐infection, is widespread in southeastern China. Hepatitis virus screening should be included in monitoring of HIV infection, and HIV and hepatitis virus co‐infection should be considered during the development of HIV antiretroviral therapy scheme. J. Med. Virol. 89:443–449, 2017.Keywords
Funding Information
- Cultivation of Young Talents Project Fund from the Health Department of Fujian Province (2015-ZQN-ZD-11)
- Pilot Project of Fujian Provincial Department of Science & Technology (2016Y0010)
This publication has 29 references indexed in Scilit:
- HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Update on epidemiology of hepatitis B and C in ChinaJournal of Gastroenterology and Hepatology, 2013
- Hepatitis C virus and HIV type 1 co-infectionInfectious Disease Reports, 2013
- Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in central ChinaArchives of Virology, 2013
- Challenges and Priorities in the Management of HIV/HBV and HIV/HCV Coinfection in Resource-Limited SettingsSeminars in Liver Disease, 2012
- Five-Year Review of HIV-Hepatitis B Virus (HBV) Co-Infected Patients in a New York City AIDS CenterJournal of Korean Medical Science, 2012
- Thirty Years of HIV and AIDS: Future Challenges and OpportunitiesAnnals of Internal Medicine, 2011
- Epidemiology of viral hepatitis and HIV co-infectionJournal of Hepatology, 2006
- Sharing of drug preparation equipment as a risk factor for hepatitis CAmerican Journal of Public Health, 2001
- HIV risk factors among injecting drug users in five US citiesAIDS, 1994